The latest price target for Imax (NYSE:IMAX) was reported by JP Morgan on December 15, 2025. The analyst firm set a price target for $47.00 expecting IMAX to rise to within 12 months (a possible 24.40% upside). 46 analyst firms have reported ratings in the last year.

The latest analyst rating for Imax (NYSE:IMAX) was provided by JP Morgan, and Imax upgraded their overweight rating.

The last upgrade for Imax Corp happened on December 15, 2025 when JP Morgan raised their price target to $47. JP Morgan previously had a neutral for Imax Corp.

There is no last downgrade for Imax.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imax was filed on December 15, 2025 so you should expect the next rating to be made available sometime around December 15, 2026.

While ratings are subjective and will change, the latest Imax (IMAX) rating was a upgraded with a price target of $32.00 to $47.00. The current price Imax (IMAX) is trading at is $37.78, which is within the analyst’s predicted range.